Quantifying the Effect Size of Exposure-Outcome Association Using δ-score: Application to Environmental Chemical Mixture studies

Vishal Midya; Jiangang Liao; Chris Gennings; Elena Colicino; Susan L. Teitelbaum; Robert O. Wright; Damaskini Valvi

doi:10.1101/2022.03.02.22271732

Abstract

Epidemiologists often study the associations between a set of exposures and multiple biologically relevant outcomes. Frequently used scale and context dependent regression coefficients may not offer practically meaningful comparison and can further complicate the interpretation when these outcomes do not have similar units. Additionally, while scaling up a hypothesis driven study based on preliminary data, epidemiologists face a major uncertainty of how large the sample size should be. Frequently used p-value based sample size calculation emphasizes on precision and might lead to very large sample size for small or moderate effect sizes. This is not only costly but also might allow detection of irrelevant effects. Here we introduced a new concept “δ-score” by modifying Cohen’s f ². δ-score is scale independent and under a new hypothesis testing framework quantifies the maximum Cohen’s f ² with certain optimal properties. We also introduced “Sufficient sample size”, which is the sample size required to attain the δ-score. Finally, we demonstrated the utility of δ-score and sufficient sample size using data on adults from 2017–2018 US National Health and Nutrition Examination Survey for association between mixture of Per-and poly-fluoroalkyl substances and metals with serum high-density and low-density lipoprotein-cholesterols.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by - National Institute of Environmental Health Science (NIEHS): P30ES023515

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

1) The aims and presentation of the paper 2) Most technical details were moved to the supplement

Data Availability

All data produced are available online at US NHANES(2017 and 2018)

https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2017

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.